| 000 | 01301 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250518063459.0 | ||
| 264 | 0 | _c20191127 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1432-0851 | ||
| 024 | 7 |
_a10.1007/s00262-019-02401-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpear, Timothy T | |
| 245 | 0 | 0 |
_aUnderstanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _cNov 2019 |
||
| 300 |
_a1881-1889 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 | _aCross Reactions |
| 650 | 0 | 4 |
_aCytotoxicity, Immunologic _ximmunology |
| 650 | 0 | 4 |
_aGenes, T-Cell Receptor _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 | _aT-Cell Antigen Receptor Specificity |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aEvavold, Brian D | |
| 700 | 1 | _aBaker, Brian M | |
| 700 | 1 | _aNishimura, Michael I | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 68 _gno. 11 _gp. 1881-1889 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00262-019-02401-0 _zAvailable from publisher's website |
| 999 |
_c30184838 _d30184838 |
||